Tag:
Oriel Therapeutics
Latest Headlines
Latest Headlines
Novartis expands generics portfolio with Oriel buy
Novartis ( NYSE: ADR ) is beefing up its generic division Sandoz with the purchase of U.S.-based Oriel Therapeutics. The deal brings a pipeline of copycat respiratory meds, a welcome addition after the
